PCI Pharma Services Digital Transformation Journey

Your bridge between life-changing therapies and patients

Interface Magazine talks to PCI Pharma Services on its strategic digital transformation journey, sharing how they are creating industry-leading customer experiences and an efficient and collaborative Pharma supply chain organization.

PCI Pharma Services is a trusted partner for pharmaceutical and biopharmaceutical companies, providing clinical and commercial supply chain solutions in the shared goal of improving patients’ lives.

PCI invests in organic growth as an innovative supply chain solutions provider delivering operational excellence. In addition, it enhances its offering through strategic acquisitions and partnerships and in doing so, meets the future needs of a global customer base. By differentiating itself, PCI continues to provide industry-leading customer experience through investment in both digital and technology and its biggest asset: people.

PCI Pharma Services Digital Transformation Journey

Digital transformation is now a key differentiation for PCI as part of its business strategy. PCI’s goal is to create new digital customer experiences, whilst achieving more collaboration and efficiency across its global organization.

Salim Haffar is a progressive CEO and it was his vision, in collaboration with the PCI Pharma Services Board, that initiated the PCI digital transformation journey. The Board, with Haffar, enlisted the services of a global digital transformation specialist, Wayne Hull, to lead the digital and technology strategy of transforming PCI’s customer experiences, business processes, and IT. “What Wayne truly brought to us and the board was a fresh perspective. Many of our leaders have spent years in the same industry, healthcare, which is highly regulated, and hence risk and change-averse. We are known for our industry leadership and how we service the customers. It’s really an exceptional DNA of customer centricity and digital and technology that’s going to add another level to how we interface with customers. It’s going to be leading-edge, scalable and differentiating, and that’s what excites me.” says Haffar.

Wayne Hull, who is now PCI’s Chief Digital and Technology Officer, led the PCI digital and technology strategy in collaboration with the company’s major private equity investor Partners Group Industry Value Creation team and the PCI executive and management team.

Continue reading the article here

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients